TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

LIQUIDIA TECH

CardiovascularRespiratory
Pharma

LIQUIDIA TECH is a pharmaceutical company focused on Cardiovascular, Respiratory. Key products include YUTREPIA.

2025
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

YUTREPIA
treprostinil sodium
Cardiovascular
7 indications · 2025

Recent Activity

YUTREPIA 2025-05-23
Type 5 - New Formulation or New Manufacturer
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs Phase 3: 4 Phase 2: 1
Respiratory 50%
1 drugs Phase 3: 4 Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Cardiovascular, Respiratory
AstraZeneca big-pharma
Respiratory, Cardiovascular
Boehringer Ingelheim big-pharma
Respiratory, Cardiovascular
GE HEALTHCARE specialty
Cardiovascular, Respiratory
BRACCO specialty
Cardiovascular, Respiratory